2017 annual financial data
Tempest Therapeutics 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was -6,894.92%.
Operating income was -20,482,000 USD and net income was -84,578,000 USD.
Operating cash flow was -20,340,000 USD.
Get free Tempest Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 295,000 USD
- Operating income
- -20,482,000 USD
- Net income
- -84,578,000 USD
- Operating cash flow
- -20,340,000 USD